Loading...
Market
Will the UK-developed urine test reduce lung cancer mortality in the EU by 10% or more by 2030?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Published studies or health reports from the EU
Story
UK Researchers Develop Urine Test Targeting Zombie Cell Proteins to Detect Early Lung Cancer, Addressing 230,000 Annual EU Deaths
Dec 6, 2024, 12:00 PM
Researchers in the United Kingdom have developed a groundbreaking urine test that can detect early signs of lung cancer by targeting specific proteins associated with 'zombie' cells. This innovative test aims to identify cancer months or even years before symptoms appear, potentially reducing the need for invasive treatments. The test has shown promising results in trials, with plans for human trials underway, according to Kevin Brindle from the Cancer Research UK Cambridge Centre. Lung cancer is a significant health issue, causing nearly 230,000 deaths annually in the European Union.
View original story
Similar markets
Yes • 50%
No • 50%
Significant survival improvement • 25%
Partial survival improvement • 25%
No significant change • 25%
Deterioration • 25%
Yes • 50%
No • 50%
0-1000 • 25%
1001-5000 • 25%
5001-10000 • 25%
10001+ • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than 5% • 25%
5% - 10% • 25%
11% - 15% • 25%
More than 15% • 25%
Rectal cancer • 25%
Breast cancer • 25%
Lung cancer • 25%
Other • 25%